Alzinova AB (publ) (ticker: ALZ) is pleased to announce the release of the drug substance for its upcoming Phase 2 clinical trial of the vaccine candidate ALZ-101 in early Alzheimer's disease. This mi ...

Despite a lot of advancements in our understanding of dementia over the past few decades, doctors still don’t have a reliable ...

Pack  The Chronicle    People who are 65 years old today can expect to live an additional 19.3 years, on average, according ...

Both GLP-1 RAs and SGLT2is are associated with a reduced risk for Alzheimer disease and related dementias among people with type 2 diabetes.

Brain tissue analysis of an animal model has revealed the potential role of immune system dysfunction in the onset and ...

Zahydie Burgos Ribot and her husband Francisco are working on completing their travel bucket list and spending quality time ...

Blood vessels located at the back of the eye could potentially signal early signs of dementia, a recent study suggests.

With a new raise provided by Flagship Pioneering, the new company is aiming to find “the silent window” before disease symptoms set in.

In Alzheimer's, Parkinson's, and type 2 diabetes, harmful protein aggregates and deposits, known as amyloid plaques, develop.

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

A recent study, published in the medical journal of the American Academy of Neurology, found that practicing seven basic ...

An extended family in that South American country has a devastating genetic variant that triggers early-onset dementia. "They ...